EW Q3'26 Earnings: EPS estimate is 0.74 USD

What happened

Edwards Lifesciences (EW) is scheduled to report its third-quarter 2026 results on November 4, after the market closes, with disclosure expected at 3:15 p.m. ET. The article lists estimated revenue of $1.68 billion and estimated earnings per share (EPS), or profit attributable to each share, of $0.74.

Confirmed

Global impact / market context

The report will show whether Edwards Lifesciences’ sales and profit per share met the listed estimates. Results above or below those figures could change investors’ expectations for the company’s revenue and costs, influencing how they value its shares and their willingness to hold them.

Analyst inference

The supplied figures show reported revenue exceeded estimates in each of the four listed quarters, while reported EPS exceeded estimates in three and fell short in one. That history provides context, but does not establish whether third-quarter 2026 results will meet expectations.

Analyst inference

What to watch

1. Check the reported third-quarter revenue against the $1.68 billion estimate; the difference will indicate whether sales were stronger or weaker than the figure listed. Confirmed
2. Compare reported EPS with the $0.74 estimate. EPS means profit per share, and a difference could affect investors’ assessment of earnings performance. Confirmed
3. Look for any company explanation of results or outlook, since changes to expected sales or costs could influence future revenue and profit expectations. Analyst inference

Evidence

• Original source link unavailable